The BET on Blood for SCD partnership between the National Alliance of Sickle Cell Centers (NASCC) and Terumo Blood and Cell Technologies is uniquely focused on addressing gaps in blood transfusion therapy accessibility and safety for people with sickle cell disease (SCD). By connecting key blood ecosystem stakeholders, including healthcare providers, advocacy groups, blood banking partners, and treatment centers, the partnership aims to drive education, access, and collaboration around blood-based therapies. Based on the belief that Blood is an Essential Therapy for Sickle Cell Warriors, the collaboration promotes the use of transfusion therapy to prevent and manage acute complications by replacing sickled red blood cells with healthy ones. Together, NASCC and Terumo BCT will work to create more personalized, effective treatment strategies and improve patients' quality of life.
Company Details
- Address
- Gaps In Access To Adequate #scd Care And Educate Healthcare Providers About How Transfusion Therapy Can Be Used To Improve Patient Outcomes.
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://sicklecellcenters.org/
- Keywords
- IT Consulting.
Bet On Blood Questions
Bet On Blood's website is https://sicklecellcenters.org/
Bet On Blood's LinkedIn profile is https://www.linkedin.com/company/bet-on-blood
Bet On Blood's industry is
Hospitals and Health Care
Bet On Blood's categories are Hospitals and Health Care
